Oligonucleotides: EMA drafts new guideline on manufacturing and development

Regulatory News

Regulatory NewsJoanne S. Eglovitch

Approval/marketing authorizationBiologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)Clinical TrialsEuropeEuropean Medicines Agency (EMA)ManufacturingPharmaceuticalsRegulatory Intelligence/PolicyRegulatory writing/documentation